X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   ADCOCK INGRAM
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
ADCOCK INGRAM
Jun-14
ALKEM LABORATORIES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,589316-   
Low Rs1,232228-   
Sales per share (Unadj.) Rs417.594.0-  
Earnings per share (Unadj.) Rs56.3-23.7-  
Cash flow per share (Unadj.) Rs64.7-19.6-  
Dividends per share (Unadj.) Rs12.700-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs292.973.8-  
Shares outstanding (eoy) m119.57168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.42.9 116.8%   
Avg P/E ratio x25.1-11.5 -218.2%  
P/CF ratio (eoy) x21.8-13.9 -157.3%  
Price / Book Value ratio x4.83.7 130.6%  
Dividend payout %22.60-   
Avg Mkt Cap Rs m168,65345,919 367.3%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m9,1712,882 318.2%   
Avg. sales/employee Rs ThNM3,696.8-  
Avg. wages/employee Rs ThNM671.3-  
Avg. net profit/employee Rs ThNM-931.5-  
INCOME DATA
Net Sales Rs m49,91515,870 314.5%  
Other income Rs m1,645111 1,480.3%   
Total revenues Rs m51,56115,982 322.6%   
Gross profit Rs m8,482-2,750 -308.4%  
Depreciation Rs m1,006685 146.8%   
Interest Rs m671430 156.0%   
Profit before tax Rs m8,451-3,754 -225.1%   
Minority Interest Rs m-114-10 1,087.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,606235 684.7%   
Profit after tax Rs m6,731-3,999 -168.3%  
Gross profit margin %17.0-17.3 -98.1%  
Effective tax rate %19.0-6.2 -304.1%   
Net profit margin %13.5-25.2 -53.5%  
BALANCE SHEET DATA
Current assets Rs m27,06211,624 232.8%   
Current liabilities Rs m15,3246,540 234.3%   
Net working cap to sales %23.532.0 73.4%  
Current ratio x1.81.8 99.4%  
Inventory Days Days67111 60.0%  
Debtors Days Days41124 33.3%  
Net fixed assets Rs m12,6106,775 186.1%   
Share capital Rs m23974 324.5%   
"Free" reserves Rs m34,4900-   
Net worth Rs m35,02712,457 281.2%   
Long term debt Rs m1,2124,377 27.7%   
Total assets Rs m54,38723,531 231.1%  
Interest coverage x13.6-7.7 -175.9%   
Debt to equity ratio x00.4 9.8%  
Sales to assets ratio x0.90.7 136.1%   
Return on assets %13.6-15.2 -89.7%  
Return on equity %19.2-32.1 -59.9%  
Return on capital %24.9-19.8 -125.5%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Net fx Rs m3,5520-   
CASH FLOW
From Operations Rs m7,2591,355 535.8%  
From Investments Rs m1,864-416 -448.2%  
From Financial Activity Rs m-9,2733,973 -233.4%  
Net Cashflow Rs m-1504,912 -3.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.36 Rs / ZAR

Compare ALKEM LABORATORIES With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare ALKEM LABORATORIES With: ABBOTT INDIA  FDC LTD.  CADILA HEALTHCARE  IPCA LABS  PANACEA BIOTECH  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 17, 2017 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - TTK HEALTHCARE COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS